Other than GI-related side effects, patients on semaglutide also report serious side effects, such as kidney problems, pancreatitis, gallbladder disease, hypoglycemia (low blood sugar), and severe allergic reactions
However, the authors urge caution in interpreting these findings due to the limited number of trials, the variations in study designs, and the heterogeneity in patient populations and substance types studied
Some compounding pharmacies have prepared it under the 503A framework, but FDA guidance has periodically flagged AOD-9604 as a bulk substance that may not qualify for compounding
Presented for research literature review only Simi T et al
Regulation of active Na+-K+ transport in skeletal muscle
Fairly Traded